post

Old Doc New Drug: Tapentadol

The second instalment of the series of newfangled pharmacological favourites for your edification. This post is all about tapentadol… and its friends.  If you are like me you probably started noticing a trickle, then a flood of patients being discharged from big city hospitals on this new drug.  Now I am a simple rural doctor.  […]

post

Old Doc, New Drugs: Levetiracetam

This is a new series of written posts I am doing for the blog.  Basic concept:  I last studied pharmacology 20 years ago. In that time a heap of new drugs have appeared in the pharmacy… and I have been using a lot of them in my practice with little or no understanding of their […]

post

First10EM Journal Club: November 2017

Welcome back to the Journal Club with Dr Justin Morgenstern.  It has been 2 months since we last dusted off the papers on Justin’s bedside table… but like a mythical (nerdy) Sisyphus Justin must push another load of evidence out into the ether in order to go back and start the whole process again. This […]

post

Pain Plan

Hello, this post is inspired by a few recent discussions that have been taking place on the FOAMed Twitter space.  It is all about how we should approach the ongoing pain for patients whom we are sending home from the ED. There is a big tension here.  We are good people; we went into Medicine […]

post

A COMPASS that points Nor’west

Today I’m on a deep dive into a newly released trial that has the potential to change the way we manage chronic, stable atherosclerotic disease.  The trial under the spotlight is the COMPASS trial (full text PDF here) published online in the NEJM on August 27, 2017.  It was launched at the European Cardiology Society (ESC) […]